Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Islet neogenesis: a potential therapeutic tool in type 1 diabetes.
Lipsett M, Aikin R, Castellarin M, Hanley S, Jamal AM, Laganiere S, Rosenberg L. Lipsett M, et al. Among authors: laganiere s. Int J Biochem Cell Biol. 2006;38(4):498-503. doi: 10.1016/j.biocel.2005.08.022. Epub 2005 Sep 27. Int J Biochem Cell Biol. 2006. PMID: 16216541 Review.
Islet neogenesis: a potential therapeutic tool in type 1 diabetes.
Lipsett M, Aikin R, Hanley S, Al-Maleek J, Laganiere S, Rosenburg L. Lipsett M, et al. Among authors: laganiere s. Int J Biochem Cell Biol. 2006;38(5-6):715-20. doi: 10.1016/j.biocel.2006.02.005. Int J Biochem Cell Biol. 2006. PMID: 16607698
Tominersen in Adults with Manifest Huntington's Disease.
McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, Zhou J, Schlegel V, Sanwald Ducray P, Hawellek DJ, Dorn J, Simillion C, Lindemann M, Wheelock V, Durr A, Anderson KE, Long JD, Wild EJ, Landwehrmeyer GB, Leavitt BR, Tabrizi SJ, Doody R; GENERATION HD1 Investigators. McColgan P, et al. N Engl J Med. 2023 Dec 7;389(23):2203-2205. doi: 10.1056/NEJMc2300400. N Engl J Med. 2023. PMID: 38055260 No abstract available.
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E, Claassen DO, Kayson E, Goldstein J, Mehanna R, Zhang H, Liang GS, Haubenberger D; Huntington Study Group KINECT-HD Collaborators. Furr Stimming E, et al. Lancet Neurol. 2023 Jun;22(6):494-504. doi: 10.1016/S1474-4422(23)00127-8. Lancet Neurol. 2023. PMID: 37210099 Clinical Trial.
51 results